Persistent Fetal Vasculature: Mechanisms of Development, Current Treatment Approaches, and Advancements in Therapy
-
By
-
Robert H. Henderson
-
October 6, 2026
Clinical Scorecard: Persistent Fetal Vasculature: Mechanisms of Development, Current Treatment Approaches, and Advancements in Therapy
At a Glance
| Category | Detail |
|---|---|
| Condition | Persistent fetal vasculature (PFV), a congenital ocular vascular-development disorder with anterior, posterior, or combined manifestations. |
| Key Mechanisms | PFV reflects impaired coordination among angiogenic drive, apoptotic regression, and ocular growth. The source describes HIF-VEGF signalling, macrophage-derived WNT7b, Norrin/FZD4/LRP5/6 β-catenin signalling, and ATOH7-associated PFV. |
| Target Population | Infants and children with congenital ocular findings such as cataract, microphthalmia, or a dense retrolental membrane. |
| Care Setting | The source describes clinical classification as anterior, posterior, or combined and management decisions based on whether surgery may benefit the eye or accelerate loss of structure and comfort. |
Key Highlights
- PFV is an important cause of infantile leucocoria and can mimic retinoblastoma.
- Among congenital cataract surgical series, PFV findings occur in approximately 20–45% of unilateral cases and 5–10% of bilateral cases.
- Bilateral PFV frequently signals a systemic or genetic syndrome, including Norrie disease and familial exudative vitreoretinopathy.
- Ultrasound with colour Doppler, wide-field fluorescein angiography, OCT, and OCT-angiography support subtype assessment and evaluation of ocular structure.
- Management requires distinguishing eyes that may benefit from surgery from those in which intervention could accelerate loss of structure and comfort.
Guideline-Based Recommendations
Diagnosis
- Classify PFV as anterior, posterior, or combined to guide clinical decisions.
Management
- Distinguish eyes that may benefit from surgery from those in which intervention would only accelerate loss of structure and comfort.
Monitoring & Follow-up
Risks
- PFV is an important cause of infantile leucocoria and can mimic retinoblastoma.
- Bilateral PFV frequently signals a systemic or genetic syndrome, including Norrie disease and familial exudative vitreoretinopathy.
- In some eyes, intervention would only accelerate loss of structure and comfort.
Patient & Prescribing Data
The article describes congenital PFV, including findings such as cataract, microphthalmia, and a dense retrolental membrane.
The supplied source passage provides no medication prescribing data and does not describe specific surgical approaches.
Clinical Best Practices
- Consider PFV in the assessment of infantile leucocoria and distinguish it carefully from retinoblastoma.
- Assess for bilateral disease and possible systemic or genetic associations.
- Use the anterior, posterior, or combined classification when considering clinical decisions.
- Distinguish eyes that may benefit from surgery from those in which intervention would only accelerate loss of structure and comfort.
Related Resources & Content
Based on findings from:
Persistent foetal vasculature: Developmental mechanisms, contemporary management and evolving therapeutics
Robert H. Henderson. Eye, 2026.
https://www.nature.com/articles/s41433-026-04959-3
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.